BackBrickell Biotech Overview

Brickell Biotech Long Term Debt

Brickell Biotech's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Brickell Biotech Long Term Debt History

Loading

Brickell Biotech vs. peers: Long Term Debt Comparison

Loading

Brickell Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Brickell Biotech (BBI) FAQ

Brickell Biotech (BBI) currently reports a long-term debt of $0 as of June 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Brickell Biotech's long-term debt history and peer comparisons.

Brickell Biotech's long-term debt changed from $0 to $0 (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Brickell Biotech reported $0 in long-term debt as of June 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Brickell Biotech, and consider following BBI for alerts when major investors trade the stock.

Brickell Biotech is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BBI with unrelated industries.